Kenji Kamiya Selected Research

Nuclear Power Plants

12/2021	Trend in Cancer Incidence and Mortality in Fukushima From 2008 Through 2015.
1/2021	Socioeconomic status, damage-related conditions, and PTSD following the Fukushima-daiichi nuclear power plant accident:The Fukushima Health Management Survey.
9/2020	Effects of Psychological and Lifestyle Factors on Metabolic Syndrome Following the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey.
7/2020	Factors Influencing the Proportion of Non-examinees in the Fukushima Health Management Survey for Childhood and Adolescent Thyroid Cancer: Results From the Baseline Survey.
3/2020	Absorbed radiation doses in the thyroid as estimated by UNSCEAR and subsequent risk of childhood thyroid cancer following the Great East Japan Earthquake.
11/2019	External Radiation Dose, Obesity, and Risk of Childhood Thyroid Cancer After the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey.
1/2018	Associations Between Childhood Thyroid Cancer and External Radiation Dose After the Fukushima Daiichi Nuclear Power Plant Accident.
12/2017	Simulation of expected childhood and adolescent thyroid cancer cases in Japan using a cancer-progression model based on the National Cancer Registry: Application to the first-round thyroid examination of the Fukushima Health Management Survey.
4/2017	Effect of evacuation on liver function after the Fukushima Daiichi Nuclear Power Plant accident: The Fukushima Health Management Survey.
1/2016	Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years After the Fukushima Daiichi Nuclear Power Plant Accident.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Kamiya Research Topics

Disease

14	Neoplasms (Cancer) 12/2021 - 07/2004
9	Thyroid Neoplasms (Thyroid Cancer) 12/2021 - 12/2003
7	Obesity 07/2021 - 01/2014
6	Genomic Instability 01/2022 - 01/2010
5	Hypertension (High Blood Pressure) 01/2022 - 09/2006
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 09/2020
3	Hyperuricemia 01/2021 - 01/2014
3	Liver Diseases (Liver Disease) 04/2017 - 01/2014
2	Multiple Myeloma 01/2021 - 07/2019
2	Adenoma (Adenomas) 01/2017 - 12/2003
2	Hyperlipidemias (Hyperlipidemia) 01/2015 - 01/2014
1	Sleep Deprivation 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020
1	Body Weight (Weight, Body) 06/2020
1	Overweight 01/2020
1	Carcinogenesis 01/2017
1	Polycythemia (Erythrocytosis) 12/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2014
1	Thymoma (Thymic Carcinoma) 01/2014
1	Ataxia (Dyssynergia) 08/2013
1	Fanconi Anemia (Fanconi's Anemia) 08/2013
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2012
1	Lung Neoplasms (Lung Cancer) 11/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2010
1	Adenocarcinoma 12/2006
1	Aberrant Crypt Foci 12/2005
1	Carcinoma (Carcinomatosis) 12/2005
1	Prostatic Neoplasms (Prostate Cancer) 07/2004
1	Neoplasm Metastasis (Metastasis) 07/2004
1	Thyroid Diseases (Thyroid Disease) 12/2003
1	Cysts 12/2003
1	Goiter 12/2003
1	Gastritis 12/2002

Drug/Important Bio-Agent (IBA)

3	oxidized low density lipoproteinIBA 01/2022 - 01/2020
3	Cyclin D1IBA 07/2019 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2004
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	HDL CholesterolIBA 07/2021 - 06/2020
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021 - 07/2019
2	LDL CholesterolIBA 06/2020 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 06/2020 - 01/2020
2	CarcinogensIBA 01/2017 - 12/2005
2	Ointments (Pastes)IBA 09/2006 - 12/2005
1	Biological ProductsIBA 01/2022
1	Uric Acid (Urate)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	LipidsIBA 06/2020
1	flowable hybrid composite (Flow-It)IBA 01/2020
1	CholesterolIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	Thyroglobulin FDA Link 01/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	Glutathione (Reduced Glutathione)IBA 03/2017
1	AntioxidantsIBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 11/2015
1	Guanosine Triphosphate (GTP)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 08/2013
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 03/2012
1	Messenger RNA (mRNA)IBA 11/2010
1	Histones (Histone)IBA 11/2010
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2010
1	DNA Polymerase IIIIBA 01/2010
1	GuanineIBA 09/2009
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 09/2009
1	Insulin (Novolin)FDA Link 04/2008
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2006
1	AminesIBA 12/2006
1	Sodium Chloride FDA LinkGeneric 09/2006
1	beta CateninIBA 12/2005
1	AzoxymethaneIBA 12/2005
1	LigandsIBA 07/2004
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2004
1	Colloids (Colloid)IBA 12/2003
1	InterferonsIBA 12/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2002
1	CytokinesIBA 12/2002

Therapy/Procedure

12	Nuclear Power Plants 12/2021 - 12/2014